Silence Therapeutics
SLN
#7428
Rank
A$0.51 B
Marketcap
$10.99
Share price
8.52%
Change (1 day)
-54.11%
Change (1 year)

Silence Therapeutics (SLN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.16 Billion

According to Silence Therapeutics's latest financial reports the company's total liabilities are A$0.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Silence Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.14 B-5.47%
2022-12-31A$0.15 B-6.96%
2021-12-31A$0.16 B19.72%
2020-12-31A$0.13 B189.24%
2019-12-31A$47.13 M583.04%
2018-12-31A$6.9 M50.04%
2017-12-31A$4.59 M66.9%
2016-12-31A$2.75 M21.18%
2015-12-31A$2.27 M-40.61%
2014-12-31A$3.82 M20.12%
2013-12-31A$3.18 M113.75%
2012-12-31A$1.49 M-21.91%
2011-12-31A$1.9 M-25.46%
2010-12-31A$2.56 M-32.36%
2009-12-31A$3.78 M95.04%
2008-12-31A$1.94 M-52.56%
2007-12-31A$4.09 M57.84%
2006-12-31A$2.59 M-25.88%
2005-12-31A$3.49 M66.75%
2004-12-31A$2.09 M-33.22%
2003-12-31A$3.14 M7.43%
2002-12-31A$2.92 M42.04%
2001-12-31A$2.05 M